Su1483 - Effect of a Novel Kappa-Receptor Agonist, Nalfurafine Hydrochloride, on Patients with Chronic Liver Disease

Gastroenterology ◽

10.1016/s0016-5085(18)32000-6 ◽

2018 ◽

Vol 154 (6) ◽

pp. S-535

Author(s):

Norio Okamoto ◽

Shinya Fukunishi ◽

Akira Asai ◽

Kazuhide Higuchi

Keyword(s):

Liver Disease ◽

Chronic Liver Disease ◽

Receptor Agonist ◽

Chronic Liver ◽

Download Full-text

Thrombopoietin receptor agonist is more effective than platelet transfusion for chronic liver disease with thrombocytopenia, shown by propensity score matching

Hepatology Research ◽

10.1111/hepr.13530 ◽

2020 ◽

Vol 50 (9) ◽

pp. 1062-1070 ◽

Author(s):

Yoshihiro Furuichi ◽

Hirohito Takeuchi ◽

Yuu Yoshimasu ◽

Yoshitaka Kasai ◽

Masakazu Abe ◽

...

Keyword(s):

Liver Disease ◽

Propensity Score ◽

Chronic Liver Disease ◽

Propensity Score Matching ◽

Receptor Agonist ◽

Platelet Transfusion ◽

Chronic Liver ◽

Thrombopoietin Receptor ◽

Thrombopoietin Receptor Agonist

Download Full-text

SAT-006-Efficacy of oral thrombopoietin receptor agonist lusutrombopag in chronic liver disease by underlying disease aetiology

Journal of Hepatology ◽

10.1016/s0618-8278(19)31249-6 ◽

2019 ◽

Vol 70 (1) ◽

pp. e627-e628 ◽

Author(s):

Naim Alkhouri ◽

Michio Imawari ◽

Namiki Izumi ◽

Yukio Osaki ◽

Toshimitsu Ochiai ◽

...

Keyword(s):

Liver Disease ◽

Chronic Liver Disease ◽

Receptor Agonist ◽

Underlying Disease ◽

Chronic Liver ◽

Thrombopoietin Receptor ◽

Disease Aetiology ◽

Thrombopoietin Receptor Agonist

Download Full-text

585 – Effect of Thrombopoietin Receptor Agonist is Higher Than that of Platelet Transfusion in Chronic Liver Disease with Thrombocytopenia –From Propensity Score Matching-

Gastroenterology ◽

10.1016/s0016-5085(19)37076-3 ◽

2019 ◽

Vol 156 (6) ◽

pp. S-113

Author(s):

Yoshihiro Furuichi ◽

Hirohito Takeuchi ◽

Masakazu Abe ◽

Yoshitaka Kasai ◽

Takao Itoi

Keyword(s):

Liver Disease ◽

Propensity Score ◽

Chronic Liver Disease ◽

Propensity Score Matching ◽

Receptor Agonist ◽

Platelet Transfusion ◽

Chronic Liver ◽

Thrombopoietin Receptor ◽

Thrombopoietin Receptor Agonist

Download Full-text

Su1684 EFFICACY OF ORAL THROMBOPOIETIN RECEPTOR AGONIST LUSUTROMBOPAG IN CHRONIC LIVER DISEASE PATIENTS UNDERGOING A GASTROINTESTINAL PROCEDURE: RESULTS FROM TWO PHASE 3 CLINICAL TRIALS

Gastroenterology ◽

10.1016/s0016-5085(20)32234-4 ◽

2020 ◽

Vol 158 (6) ◽

pp. S-614

Author(s):

Martin Moehlen ◽

Mark Semaan ◽

Takeshi Kano ◽

Toshimitsu Ochiai

Keyword(s):

Clinical Trials ◽

Liver Disease ◽

Chronic Liver Disease ◽

Receptor Agonist ◽

Chronic Liver ◽

Phase 3 ◽

Two Phase ◽

Thrombopoietin Receptor ◽

Thrombopoietin Receptor Agonist

Download Full-text

The Thrombopoietin Receptor Agonist Lusutrombopag Is Effective for Patients with Chronic Liver Disease and Impaired Renal Function

Journal of Nippon Medical School ◽

10.1272/jnms.jnms.2020_87-603 ◽

2020 ◽

Vol 87 (6) ◽

pp. 325-333

Author(s):

Hirohito Takeuchi ◽

Yoshihiro Furuichi ◽

Yu Yoshimasu ◽

Yoshitaka Kasai ◽

Masakazu Abe ◽

...

Keyword(s):

Renal Function ◽

Liver Disease ◽

Chronic Liver Disease ◽

Impaired Renal Function ◽

Receptor Agonist ◽

Chronic Liver ◽

Thrombopoietin Receptor ◽

Thrombopoietin Receptor Agonist

Download Full-text

Pharmacokinetic/Pharmacodynamic Modelling and Simulation of Lusutrombopag, a Novel Thrombopoietin Receptor Agonist, for the Treatment of Thrombocytopenia in Patients with Chronic Liver Disease Undergoing Invasive Procedures

Clinical Pharmacokinetics ◽

10.1007/s40262-019-00770-4 ◽

2019 ◽

Vol 58 (11) ◽

pp. 1469-1482 ◽

Author(s):

Takayuki Katsube ◽

Ryosuke Shimizu ◽

Takahiro Fukuhara ◽

Takeshi Kano ◽

Toshihiro Wajima

Keyword(s):

Liver Disease ◽

Chronic Liver Disease ◽

Receptor Agonist ◽

Modelling And Simulation ◽

Chronic Liver ◽

Invasive Procedures ◽

Pharmacodynamic Modelling ◽

Thrombopoietin Receptor ◽

Thrombopoietin Receptor Agonist

Download Full-text

Stable Liver Function during Long-Term Administration of Eltrombopag, a Thrombopoietin Receptor Agonist, in Patients with Chronic Liver Disease

The Tohoku Journal of Experimental Medicine ◽

10.1620/tjem.240.277 ◽

2016 ◽

Vol 240 (4) ◽

pp. 277-279 ◽

Author(s):

Tomohiro Kurokawa ◽

Soichiro Murata ◽

Nobuhiro Ohkohchi

Keyword(s):

Liver Disease ◽

Liver Function ◽

Chronic Liver Disease ◽

Receptor Agonist ◽

Chronic Liver ◽

Thrombopoietin Receptor ◽

Thrombopoietin Receptor Agonist ◽

Term Administration

Download Full-text

The Editors welcome topical correspondence from readers relating to articles published in the Journal. Responses can be sent electronically via the BJS website (www.bjs.co.uk) or by post. All letters will be reviewed and, if approved, appear on the website. A selection of these will be edited and published in the Journal. Letters must be no more than 250 words in length. Letters submitted by post should be typed on A4-sized paper in double spacing and should be accompanied by a disk. . Saphenoperitoneal shunts for patients with intractable ascites associated with chronic liver disease (Br J Surg 1999; 86: 882-5)

British Journal of Surgery ◽

10.1046/j.1365-2168.2002.20091.x ◽

2002 ◽

Vol 89 (2) ◽

pp. 245-248

Author(s):

G. A. Vercruysse ◽

D. N. Reed Jr

Keyword(s):

Liver Disease ◽

Chronic Liver Disease ◽

Chronic Liver ◽

Intractable Ascites ◽

Download Full-text

Genetic predictors of spontaneous viral elimination or chronic liver disease in hepatitis C infection

Gastroenterology ◽

10.1016/s0016-5085(01)80033-0 ◽

2001 ◽

Vol 120 (5) ◽

pp. A7-A7

Author(s):

S ROSS ◽

S MASCHERETTI ◽

H HINRICHSEN ◽

P BUGGISCH ◽

U FOELSCH ◽

...

Keyword(s):

Liver Disease ◽

Hepatitis C ◽

Chronic Liver Disease ◽

Chronic Liver ◽

Hepatitis C Infection ◽

Genetic Predictors

Download Full-text

Low levels of Thrombin Activatable Fibrinolysis Inhibitor (TAFI) in chronic liver disease

Gastroenterology ◽

10.1016/s0016-5085(01)81870-9 ◽

2001 ◽

Vol 120 (5) ◽

pp. A376-A376

Author(s):

D VANTHIEL ◽

M GEORGE ◽

J AMIRAL

Keyword(s):

Liver Disease ◽

Chronic Liver Disease ◽

Chronic Liver ◽

Thrombin Activatable Fibrinolysis Inhibitor ◽

Fibrinolysis Inhibitor ◽

Download Full-text